Ten companies from the UW startup ecosystem pitched to investors at our biannual CoMotion DubPitch event held last month at Maple Hall near the UW campus. DubPitch gives investors the opportunity to learn more about UW spinoffs and CoMotion supported startups, and allows UW researchers and startups to make valuable connections to investors who have the potential to fuel their businesses.
This fall, the event featured startups from the clean energy, predictive analytics, and biotech sectors. A highly anticipated event by the thriving Seattle entrepreneurial community, investors in attendance included representatives from GreenBridge, Microsoft, SeaChange Fund, Trilogy Equity Partners, Venture Advisors, Voyager Capital, Vulcan, WRF Capital and more.
The startups each had ten minutes to give their pitch to attendees. Afterward, investors mingled with the startups to learn more about the exciting businesses they are building.
Our next CoMotion DubPitch will be held in spring 2020. Investors interested in attending may contact us here.
In case you missed it, here is a brief overview of the startups who presented:
A novel immunotherapeutic platform for treatment of cancer and chronic infection, with a lead drug candidate for hepatitis B virus infection ready for clinical development.
A software tool that can increase the speed, diversity, accuracy, and cost-efficiency of a design project by predicting how attractive changes to a website will be to a particular target audience anywhere in the world.
Helps solar panel manufacturers dramatically improve gross margins by boosting the power output of a solar cell by up to 20%.
Created a reliable and affordable traumatic brain injury diagnosis tool by turning your smart phone into a pupilometer.
Developed suite of hardware and software resuscitation improvement products, including CodeBlue IQ and RevivePro, such that once a heart stops beating, it will bring patients back to life.
Developed and recently introduced onto the market microMend®, an innovative wound closure product. It incorporates miniature staples, Microstaples, into an adhesive backing which provides the holding strength of a suture and is as fast and easy to apply as a bandage.
The Nanodropper is a patent-pending, FDA-cleared, award-winning, universal adaptor for eyedrop medication bottles that creates smaller and more efficacious droplets to extend bottle-life, decrease cost, and ultimately increase access to expensive medications.
Solves the chaos and confusion of designing and building new homes by matching homebuyers with land, certified builders, construction lenders, modifiable house plans, and offers an Amazon-like storefront for interior and exterior product selections.
Developing small molecule cancer drug treatments that will provide “immunotherapy for all,” reducing toxicity and increasing the durability of cancer cures.
TourniTek prevents amputation and disability by treating injuries prior to surgical care using therapeutic cooling to preserve injured limbs in the field until patients can be transported to a trauma center. TourniTek is the first pre-hospital treatment for limb-threatening injuries.